Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants

JAMA Netw Open. 2024 Apr 1;7(4):e247421. DOI: 10.1001/jamanetworkopen.2024.7421

Zhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, Heidi D Nelson, Ellen M Velie, Virginia F Borges, Emma R Woodward, D Gareth R Evans, Pepper J Schedin

https://pubmed.ncbi.nlm.nih.gov/38639936/

Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2

J Med Genet. 2024 Apr 12:jmg-2023-109826. DOI: 10.1136/jmg-2023-109826 Online ahead of print.

D Gareth Evans, George J Burghel, Sacha J Howell, Sarah Pugh, Claire Forde, Anthony Howell, Fiona Lalloo, Emma Roisin Woodward

https://pubmed.ncbi.nlm.nih.gov/38609177

A randomised controlled trial of Pre-Operative Oncotype DX testing in early-stage breast cancer (PRE-DX study) – Study protocol

PLoS One. 2024 Mar 15;19(3):e0300339. DOI: 10.1371/journal.pone.0300339 eCollection 2024.

Matthew Northgraves, Judith Cohen, James Harvey, Chao Huang, Carlo Palmieri, Sarah Pinder, Pankaj Roy, Sarah Reynia, Marta Soares, Henry Cain

https://pubmed.ncbi.nlm.nih.gov/38489298

Emotion constructs and outcome measures following false positive breast screening test results: A systematic review of reporting clarity and selection rationale

Psychooncology. 2024 Apr;33(4):e6334. DOI: 10.1002/pon.6334

Hannah A Long, Sarah Hindmarch, John-Paul Martindale, Joanna M Brooks, Michelle Harvie, David P French

https://pubmed.ncbi.nlm.nih.gov/38549216/

Healthcare professionals’ experiences of caring for women with false-positive screening test results in the National Health Service Breast Screening Programme

Health Expect. 2024 Apr;27(2):e14023. DOI: 10.1111/hex.14023

Hannah A Long, Joanna M Brooks, Anthony J Maxwell, Sarah Peters, Michelle Harvie, David P French

https://pubmed.ncbi.nlm.nih.gov/38509776

EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer

Eur J Hum Genet. 2024 Mar 5. DOI: 10.1038/s41431-023-01507-5 Online ahead of print.

Trudi McDevitt^#, Miranda Durkie^#, Norbert Arnold, George J Burghel, Samantha Butler, Kathleen B M Claes, Peter Logan, Rachel Robinson, Katie Sheils, Nicola Wolstenholme, Helen Hanson, Clare Turnbull, Stacey Hume^#

https://pubmed.ncbi.nlm.nih.gov/38443545

Body composition changes during breast cancer preventive treatment with anastrozole: Findings from the IBIS-II trial

Prev Med Rep. 2024 Jan 22:38:102620. DOI: 10.1016/j.pmedr.2024.102620 eCollection 2024 Feb.

Mary Pegington, Hui Zhen Tam, Adam Brentnall, Ivana Sestak, Judith Adams, Glen M Blake, D Gareth Evans, Anthony Howell, Jack Cuzick, Michelle Harvie

https://pubmed.ncbi.nlm.nih.gov/38375161

A Retrospective Audit of the Triage Process Introduced for Breast Referrals Received During the Covid-19 Pandemic

Clin Breast Cancer. 2024 Jan 20:S1526-8209(24)00020-X. DOI: 10.1016/j.clbc.2024.01.010 Online ahead of print.

Emma Mackender, Rajiv Dave, Daisy Tudor, James Harvey

https://pubmed.ncbi.nlm.nih.gov/38368248/

Does following a breast cancer patient for a day enhance medical student empathy?

Med Teach. 2024 Feb 12:1-6. DOI: 10.1080/0142159X.2024.2311864 Online ahead of print.

Lester Barr, Bethan Daniel

https://pubmed.ncbi.nlm.nih.gov/38346423

Wire- and radiofrequency identification tag-guided localization of impalpable breast lesions: iBRA-NET localization study

Br J Surg. 2024 Jan 31;111(2):znae007. DOI: 10.1093/bjs/znae007

James Harvey, Jenna Morgan, Simon Lowes, Robert Milligan, Emma Barrett, Amtul Carmichael, Suzanne Elgammal, Tahir Masudi, Chris Holcombe, Yazan Masannat, Shelley Potter, Rajiv V Dave; iBRA-Net Localization Study Collaborative

https://pubmed.ncbi.nlm.nih.gov/38326941